Vernal Biosciences has received $21 million from investors and is expanding to a new laboratory in Essex next year.
Vernal Biosciences has raised $21 million to build a manufacturing facility in Essex that will scale up the business from supporting research to being involved in clinical trials.
Vernal Biosciences announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions.
We are excited to announce the addition of two new members to the Vernal team: Scott Vanson, Ph.D. and JJ Bivona, Ph.D.
Vernal Biosciences has been awarded a $99,475 grant from the Vermont Training Program (VTP).
We recently completed a biodistribution study of lipid nanoparticles containing mRNA encoding luciferase in mice.
Vernal Biosciences in Colchester helps make mRNA, which acts as a kind of roadmap a cell uses to make a specific protein.
Five years ago, when Christian Cobaugh had the idea of starting a biotech company to manufacture mRNA, the genetic term wasn't in the vernacular of most nonscientists.
We announced the closing of a seed round of financing today.